[HTML][HTML] Telomerase mutations in smokers with severe emphysema

SE Stanley, JJL Chen, JD Podlevsky… - The Journal of …, 2015 - Am Soc Clin Investig
SE Stanley, JJL Chen, JD Podlevsky, JK Alder, NN Hansel, RA Mathias, X Qi, NM Rafaels
The Journal of clinical investigation, 2015Am Soc Clin Investig
Mutations in the essential telomerase genes TERT and TR cause familial pulmonary fibrosis;
however, in telomerase-null mice, short telomeres predispose to emphysema after chronic
cigarette smoke exposure. Here, we tested whether telomerase mutations are a risk factor
for human emphysema by examining their frequency in smokers with chronic obstructive
pulmonary disease (COPD). Across two independent cohorts, we found 3 of 292 severe
COPD cases carried deleterious mutations in TERT (1%). This prevalence is comparable to …
Mutations in the essential telomerase genes TERT and TR cause familial pulmonary fibrosis; however, in telomerase-null mice, short telomeres predispose to emphysema after chronic cigarette smoke exposure. Here, we tested whether telomerase mutations are a risk factor for human emphysema by examining their frequency in smokers with chronic obstructive pulmonary disease (COPD). Across two independent cohorts, we found 3 of 292 severe COPD cases carried deleterious mutations in TERT (1%). This prevalence is comparable to the frequency of alpha-1 antitrypsin deficiency documented in this population. The TERT mutations compromised telomerase catalytic activity, and mutation carriers had short telomeres. Telomerase mutation carriers with emphysema were predominantly female and had an increased incidence of pneumothorax. In families, emphysema showed an autosomal dominant inheritance pattern, along with pulmonary fibrosis and other telomere syndrome features, but manifested only in smokers. Our findings identify germline mutations in telomerase as a Mendelian risk factor for COPD susceptibility that clusters in autosomal dominant families with telomere-mediated disease including pulmonary fibrosis.
The Journal of Clinical Investigation